Ilaprazole
Ilaprazole is a pharmaceutical drug with 16 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
2
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
14 of 14 finished
0.0%
0 ended early
1
trials recruiting
16
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac
Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD
Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.
Clinical Trials (16)
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac
Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD
Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.
The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker
The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori
Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment
Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety
Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic Polymorphism
Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
Efficacy Study of Ilaprazole to Treat Erosive Esophgitis
All 16 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 16